Metabolic Changes Induced by Genetically Modified Potatoes

NCT ID: NCT00953966

Last Updated: 2009-08-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-06-30

Study Completion Date

2009-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Starches from genetically modified potatoes, which differed in terms of amylose, amylopectin and phosphate content, were tested in a human randomized controlled trial.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glucose Metabolism Endocrine Metabolism Satiety

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Starch 1

Starch 1

Group Type OTHER

Genetically modified potatoes

Intervention Type OTHER

Starch from genetically modified potatoes

Starch 2

Starch 2

Group Type OTHER

Genetically modified potatoes

Intervention Type OTHER

Starch from genetically modified potatoes

Starch 3

Starch 3

Group Type OTHER

Genetically modified potatoes

Intervention Type OTHER

Starch from genetically modified potatoes

Starch 4

Starch 4

Group Type OTHER

Genetically modified potatoes

Intervention Type OTHER

Starch from genetically modified potatoes

Starch 5

Starch 5

Group Type OTHER

Genetically modified potatoes

Intervention Type OTHER

Starch from genetically modified potatoes

Starch 6

Starch 6

Group Type OTHER

Genetically modified potatoes

Intervention Type OTHER

Starch from genetically modified potatoes

Starch 7

Starch 7

Group Type OTHER

Genetically modified potatoes

Intervention Type OTHER

Starch from genetically modified potatoes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Genetically modified potatoes

Starch from genetically modified potatoes

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy males

Exclusion Criteria

* no acute oder severe chronic diseases
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Charite University, Berlin, Germany

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Charite University, Berlin, Germany

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Charité, Dept. of Endocrinology, Diabetes and Nutrition

Berlin, State of Berlin, Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Joachim Spranger, MD

Role: CONTACT

0049308445 ext. 2114

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Joachim Spranger, MD

Role: primary

0049308445 ext. 2114

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EA4/069/07

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mediterranean Diet and Blood Sugar Study
NCT07229781 NOT_YET_RECRUITING NA
Diet and Health in Adults With Metabolic Syndrome
NCT03935048 ACTIVE_NOT_RECRUITING NA